SCHEMBL7946206

SCHEMBL7946206

CCS(=O)(=O)c1ccc(C)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44
KDR P35968 1/20 0.44
PTGS2 P35354 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GAA P10253 1/20 0.44
PSIP1 O75475 2/20 0.43
CA2 P00918 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601374 0.83 MAPK1 (0.48) GAAPSIP1PTGDR2ALDH1A1MAPT
SCHEMBL1755241 0.82 PTGDR2 (0.46) FLT1FLT4KDRPTGS2SMN1; SMN2
SCHEMBL5936707 0.81 LMNA (0.50) FLT1FLT4KDRPTGS2SMN1; SMN2
SCHEMBL8765860 0.80 CA2 (0.54) FLT1FLT4KDRSMN1; SMN2CA2
SCHEMBL7948250 0.80 GAA (0.44) GAAPSIP1CA2PTGDR2ALDH1A1
SCHEMBL31531993 0.79 FLT1 (0.50) FLT1FLT4KDRPTGS2SMN1; SMN2
SCHEMBL863161 0.79 PTGS2 (0.58) FLT1FLT4KDRPTGS2CA2
SCHEMBL3386873 0.79 FLT1 (0.50) FLT1FLT4KDRPTGS2SMN1; SMN2
SCHEMBL242381 0.79 FLT1 (0.46) FLT1FLT4KDRPTGS2CA2
SCHEMBL29296542 0.79 GAA (0.43) FLT1FLT4KDRPTGS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773616-B1 PESTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2020-02-19 EP disclosed
US-20150259352-A1 Chemical Compounds PFIZER LTD (GB) 2015-09-17 US disclosed
US-20150105396-A1 Chemical Compounds PFIZER LTD (GB) 2015-04-16 US disclosed
US-8952008-B2 Chemical compounds PFIZER LIMITED (GB) 2015-02-10 US disclosed
US-20140171435-A1 Chemical Compounds PFIZER LIMITED (GB) 2014-06-19 US disclosed
US-6258984-B1 CHLORINATION OF P-ALKYLBENZENESULFONYL CHLORIDE CLARIANT GMBH (DE) 2001-07-10 US disclosed
EP-0619303-B1 4-alkyl-3-chloro-benzenesulfinic acids, 4-alkyl-3-chloro-benzenesulfonic acids, 4-alkyl-3-chloro-alkylsulfonylbenzenes and process for their preparation HOECHST AG (DE) 1997-08-13 EP disclosed
EP-0571405-B1 Process for preparing 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and intermediates HOECHST AG (DE) 1996-05-01 EP disclosed
US-5498798-A 4-alkyl-3-chlorobenzenesulfinic acids, 4-alkyl-3-chlorobenzenesulfonylcarboxylic acids, 4-alkyl-3-chloroalkylsulfonylbenzenes and preparation thereof HOECHST AG (DE) 1996-03-12 US disclosed
EP-0619303-A1 4-alkyl-3-chloro-benzenesulfinic acids, 4-alkyl-3-chloro-benzenesulfonic acids, 4-alkyl-3-chloro-alkylsulfonylbenzenes and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1994-10-12 EP disclosed
EP-0500639-B1 PROCESS FOR THE PRODUCTION OF ALKYL-(3-CHLOROPHENYL) SULPHONES HOECHST AG (DE) 1994-08-03 EP disclosed
EP-0571405-A1 PROCESS FOR PREPARING 4-ALKYLSULFONYL-1-ALKYL-2-CHLOROBENZENES AND THE LIKE. HOECHST AG (DE) 1993-12-01 EP disclosed
US-5241120-A PROCESS FOR THE PREPARATION OF ALKYL 3-CHLOROPHENYL SULFONES HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-31 US disclosed
WO-1992014700-A1 PROCESS FOR PREPARING 4-ALKYLSULFONYL-1-ALKYL-2-CHLOROBENZENES AND THE LIKE HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-03 WO disclosed
EP-0500639-A1 PROCESS FOR THE PRODUCTION OF ALKYL-(3-CHLOROPHENYL) SULPHONES. HOECHST AG (DE) 1992-09-02 EP disclosed
WO-1991007384-A1 PROCESS FOR THE PRODUCTION OF ALKYL-(3-CHLOROPHENYL) SULPHONES HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259352-A1 Chemical Compounds GABRA5, GABRA4, GABRA3 FLT1 2098/4885FLT4 1412/4885KDR 1155/4885
US-20150105396-A1 Chemical Compounds GABRA5, GABRA4, GABRA3 FLT1 2098/4885FLT4 1412/4885KDR 1155/4885
US-20140171435-A1 Chemical Compounds GABRA5, GABRA4, GABRA3 FLT1 2098/4885FLT4 1412/4885KDR 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.